Up-regulation of MDA-BF-1, a secreted isoform of ErbB3, in metastatic prostate cancer cells and activated osteoblasts in bone marrow

Funda Vakar-Lopez, Chien Jui Cheng, Jeri Kim, Gary G. Shi, Patricia Troncoso, Shi Ming Tu, Li Yuan Yu-Lee, Sue Hwa Lin

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Prostate cancer (PCa) has a propensity to metastasize to bone. The identification of molecules that mediate the biological interactions between PCa cells and the bone environment is crucial to the understanding of PCa bone metastasis. The present study has used protein purification to identify bone metastasis-related factors present in bone marrow aspirates from PCa patients with bone metastasis. MDA-BF-1 was the first bone metastasis factor to be identified and is a secreted isoform of the ErbB3 growth factor receptor. To determine which cell types in PCa bone metastases express MDA-BF-1, MDA-BF-1 expression was studied in both primary and metastatic PCa cells, using an antibody to the extracellular domain (Ab10) and another to the cytoplasmic domain (RTJ.2) of ErbB3 to distinguish MDA-BF-1 from p180-ErbB3. It was found that epithelial cells in primary PCa did not express MDA-BF-1. In contrast, epithelial cells in 41 of 45 PCa metastases (18 of 19 lymph node metastases and 23 of 26 bone metastases), and activated osteoblasts in bone metastases, expressed MDA-BF-1. In addition, newly formed bone matrices adjacent to activated osteoblasts were also immunopositive for MDA-BF-1, suggesting that activated osteoblasts secrete MDA-BF-1. These observations indicate that MDA-BF-1 is up-regulated in metastatic PCa and raise the interesting possibility that MDA-BF-1 may play a role in the metastasis and progression of PCa, particularly in bone.

Original languageEnglish
Pages (from-to)688-695
Number of pages8
JournalJournal of Pathology
Volume203
Issue number2
DOIs
Publication statusPublished - Jun 2004
Externally publishedYes

Fingerprint

Osteoblasts
Prostatic Neoplasms
Protein Isoforms
Up-Regulation
Bone Marrow
Neoplasm Metastasis
Bone and Bones
Bone Neoplasms
Epithelial Cells
Bone Matrix
Growth Factor Receptors
Lymph Nodes
Antibodies

Keywords

  • Bone metastasis
  • ErbB3
  • Lymph node metastasis
  • MDA-BF-1
  • Osteoblast
  • Prostate cancer
  • Prostatic intraepithelial neoplasia

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Up-regulation of MDA-BF-1, a secreted isoform of ErbB3, in metastatic prostate cancer cells and activated osteoblasts in bone marrow. / Vakar-Lopez, Funda; Cheng, Chien Jui; Kim, Jeri; Shi, Gary G.; Troncoso, Patricia; Tu, Shi Ming; Yu-Lee, Li Yuan; Lin, Sue Hwa.

In: Journal of Pathology, Vol. 203, No. 2, 06.2004, p. 688-695.

Research output: Contribution to journalArticle

Vakar-Lopez, Funda ; Cheng, Chien Jui ; Kim, Jeri ; Shi, Gary G. ; Troncoso, Patricia ; Tu, Shi Ming ; Yu-Lee, Li Yuan ; Lin, Sue Hwa. / Up-regulation of MDA-BF-1, a secreted isoform of ErbB3, in metastatic prostate cancer cells and activated osteoblasts in bone marrow. In: Journal of Pathology. 2004 ; Vol. 203, No. 2. pp. 688-695.
@article{4e0e03c968aa4300a1cee88809d96979,
title = "Up-regulation of MDA-BF-1, a secreted isoform of ErbB3, in metastatic prostate cancer cells and activated osteoblasts in bone marrow",
abstract = "Prostate cancer (PCa) has a propensity to metastasize to bone. The identification of molecules that mediate the biological interactions between PCa cells and the bone environment is crucial to the understanding of PCa bone metastasis. The present study has used protein purification to identify bone metastasis-related factors present in bone marrow aspirates from PCa patients with bone metastasis. MDA-BF-1 was the first bone metastasis factor to be identified and is a secreted isoform of the ErbB3 growth factor receptor. To determine which cell types in PCa bone metastases express MDA-BF-1, MDA-BF-1 expression was studied in both primary and metastatic PCa cells, using an antibody to the extracellular domain (Ab10) and another to the cytoplasmic domain (RTJ.2) of ErbB3 to distinguish MDA-BF-1 from p180-ErbB3. It was found that epithelial cells in primary PCa did not express MDA-BF-1. In contrast, epithelial cells in 41 of 45 PCa metastases (18 of 19 lymph node metastases and 23 of 26 bone metastases), and activated osteoblasts in bone metastases, expressed MDA-BF-1. In addition, newly formed bone matrices adjacent to activated osteoblasts were also immunopositive for MDA-BF-1, suggesting that activated osteoblasts secrete MDA-BF-1. These observations indicate that MDA-BF-1 is up-regulated in metastatic PCa and raise the interesting possibility that MDA-BF-1 may play a role in the metastasis and progression of PCa, particularly in bone.",
keywords = "Bone metastasis, ErbB3, Lymph node metastasis, MDA-BF-1, Osteoblast, Prostate cancer, Prostatic intraepithelial neoplasia",
author = "Funda Vakar-Lopez and Cheng, {Chien Jui} and Jeri Kim and Shi, {Gary G.} and Patricia Troncoso and Tu, {Shi Ming} and Yu-Lee, {Li Yuan} and Lin, {Sue Hwa}",
year = "2004",
month = "6",
doi = "10.1002/path.1568",
language = "English",
volume = "203",
pages = "688--695",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Up-regulation of MDA-BF-1, a secreted isoform of ErbB3, in metastatic prostate cancer cells and activated osteoblasts in bone marrow

AU - Vakar-Lopez, Funda

AU - Cheng, Chien Jui

AU - Kim, Jeri

AU - Shi, Gary G.

AU - Troncoso, Patricia

AU - Tu, Shi Ming

AU - Yu-Lee, Li Yuan

AU - Lin, Sue Hwa

PY - 2004/6

Y1 - 2004/6

N2 - Prostate cancer (PCa) has a propensity to metastasize to bone. The identification of molecules that mediate the biological interactions between PCa cells and the bone environment is crucial to the understanding of PCa bone metastasis. The present study has used protein purification to identify bone metastasis-related factors present in bone marrow aspirates from PCa patients with bone metastasis. MDA-BF-1 was the first bone metastasis factor to be identified and is a secreted isoform of the ErbB3 growth factor receptor. To determine which cell types in PCa bone metastases express MDA-BF-1, MDA-BF-1 expression was studied in both primary and metastatic PCa cells, using an antibody to the extracellular domain (Ab10) and another to the cytoplasmic domain (RTJ.2) of ErbB3 to distinguish MDA-BF-1 from p180-ErbB3. It was found that epithelial cells in primary PCa did not express MDA-BF-1. In contrast, epithelial cells in 41 of 45 PCa metastases (18 of 19 lymph node metastases and 23 of 26 bone metastases), and activated osteoblasts in bone metastases, expressed MDA-BF-1. In addition, newly formed bone matrices adjacent to activated osteoblasts were also immunopositive for MDA-BF-1, suggesting that activated osteoblasts secrete MDA-BF-1. These observations indicate that MDA-BF-1 is up-regulated in metastatic PCa and raise the interesting possibility that MDA-BF-1 may play a role in the metastasis and progression of PCa, particularly in bone.

AB - Prostate cancer (PCa) has a propensity to metastasize to bone. The identification of molecules that mediate the biological interactions between PCa cells and the bone environment is crucial to the understanding of PCa bone metastasis. The present study has used protein purification to identify bone metastasis-related factors present in bone marrow aspirates from PCa patients with bone metastasis. MDA-BF-1 was the first bone metastasis factor to be identified and is a secreted isoform of the ErbB3 growth factor receptor. To determine which cell types in PCa bone metastases express MDA-BF-1, MDA-BF-1 expression was studied in both primary and metastatic PCa cells, using an antibody to the extracellular domain (Ab10) and another to the cytoplasmic domain (RTJ.2) of ErbB3 to distinguish MDA-BF-1 from p180-ErbB3. It was found that epithelial cells in primary PCa did not express MDA-BF-1. In contrast, epithelial cells in 41 of 45 PCa metastases (18 of 19 lymph node metastases and 23 of 26 bone metastases), and activated osteoblasts in bone metastases, expressed MDA-BF-1. In addition, newly formed bone matrices adjacent to activated osteoblasts were also immunopositive for MDA-BF-1, suggesting that activated osteoblasts secrete MDA-BF-1. These observations indicate that MDA-BF-1 is up-regulated in metastatic PCa and raise the interesting possibility that MDA-BF-1 may play a role in the metastasis and progression of PCa, particularly in bone.

KW - Bone metastasis

KW - ErbB3

KW - Lymph node metastasis

KW - MDA-BF-1

KW - Osteoblast

KW - Prostate cancer

KW - Prostatic intraepithelial neoplasia

UR - http://www.scopus.com/inward/record.url?scp=2642532758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2642532758&partnerID=8YFLogxK

U2 - 10.1002/path.1568

DO - 10.1002/path.1568

M3 - Article

C2 - 15141384

AN - SCOPUS:2642532758

VL - 203

SP - 688

EP - 695

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 2

ER -